drugset / Trial / NCT01823939
PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera
RandomizedSingle-groupOpen-labelTreatment
Summary
This study will assess if the pharmacokinetics, safety and tolerability of iOWH032 are grossly different in 1) Bangladeshi healthy population and 2) Bangladeshi cholera patients. This is not a hypothesis-driven research study.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iOWH032 | Small molecule | 300 mg | Oral |